Apo CII is a lipoprotein lipase (LPL) cofactor, the enzyme that hydrolyzes triglycerides, and apo-CII deficiency stimulates hypertriglyceridemia, an independent atherosclerosis risk factor. This evidence concerns the gene LPL and atherosclerosis.